🧪 Hypotheses

mechanistic 0.96

GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Clearance

🧬 GRIN2B 🏥 neuroscience 📖 30🏛 4

✅ 0.85 ✨ 0.78 💥 0.82

## Mechanistic Overview...

mechanistic 0.95

Cortico-Striatal Synchrony Restoration via NMDA Modulation

🧬 GRIN2B 🏥 neuroscience 📖 15🏛 3

✅ 0.78 ✨ 0.34 💥 0.80

**Molecular Mechanism and Rationale**...

mechanistic 0.94

Microglial-Mediated Tau Clearance Dysfunction via TREM2 Receptor Impairment

🧬 MAPT 🏥 neuroscience 📖 17🏛 3

✅ 0.77 ✨ 0.56 💥 0.79

**Molecular Mechanism and Rationale**...

mechanistic 0.92

Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurodegeneration

🧬 NLRP3, CASP1, IL1B, PYCARD 🏥 neurodegeneration 📖 51🏛 1

✅ 0.72 ✨ 0.50 💥 0.00

## Mechanistic Overview...

mechanistic 0.89

SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senescence

🧬 SIRT1 🏥 neurodegeneration 📖 61🏛 3

✅ 0.80 ✨ 0.70 💥 0.76

## Mechanistic Overview...

mechanistic 0.89

TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration

🧬 TREM2 🏥 neurodegeneration 📖 21🏛 3

✅ 0.68 ✨ 0.72 💥 0.82

## Mechanistic Overview...

mechanistic 0.89

ACSL4-Driven Ferroptotic Priming in Disease-Associated Microglia

🧬 ACSL4 🏥 alzheimers 📖 56🏛 3

✅ 0.75 ✨ 0.85 💥 0.85

## Mechanistic Overview...

mechanistic 0.85

Prime Editing Precision Correction of APOE4 to APOE3 in Microglia

🧬 APOE 🏥 neurodegeneration 📖 28🏛 3

✅ 0.65 ✨ 0.80 💥 0.85

## Mechanistic Overview...

mechanistic 0.83

IL-6 Trans-Signaling Blockade at the Oligodendrocyte-Microglia Interface

🧬 IL6R, IL6 🏥 neuroinflammation 📖 29🏛 1

✅ 0.72 ✨ 0.65 💥 0.80

## Mechanistic Overview...

mechanistic 0.82

Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 Proteinopathy Neuroinflammation in ALS/FTD

🧬 AIM2, CASP1, IL1B, PYCARD, TARDBP 🏥 neurodegeneration 📖 31🏛 1

✅ 0.60 ✨ 0.64 💥 0.00

## Mechanistic Overview...

mechanistic 0.82

SASP-Mediated Complement Cascade Amplification

🧬 C1Q/C3 🏥 neurodegeneration 📖 38🏛 3

✅ 0.73 ✨ 0.71 💥 0.76

## Mechanistic Overview...

mechanistic 0.82

Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-Synuclein Aggregates Drives Non-Cell-Autonomous Neurodegenera

🧬 NLRP3, CASP1, IL1B, PYCARD 🏥 neurodegeneration 📖 31🏛 1

✅ 0.62 ✨ 0.50 💥 0.00

## Mechanistic Overview...

mechanistic 0.81

Mitochondrial DAMPs-Driven AIM2 Inflammasome Activation in Neurodegeneration

🧬 AIM2, CASP1, IL1B, PYCARD 🏥 neurodegeneration 📖 31🏛 1

✅ 0.66 ✨ 0.53 💥 0.00

## Mechanistic Overview...

mechanistic 0.80

Calcium-Dysregulated mPTP Opening as an Alternative mtDNA Release Mechanism for AIM2 Inflammasome Activation in Neurodeg

🧬 AIM2, CASP1, IL1B, PYCARD, PPIF 🏥 neurodegeneration 📖 31🏛 1

✅ 0.64 ✨ 0.52 💥 0.00

## Mechanistic Overview...

mechanistic 0.80

Mitochondrial DNA-Driven AIM2 Inflammasome Activation in Neurodegeneration

🧬 AIM2, CASP1, IL1B, PYCARD 🏥 neurodegeneration 📖 31🏛 1

✅ 0.66 ✨ 0.52 💥 0.00

## Mechanistic Overview...

mechanistic 0.80

40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Selectively Eliminate Disease-Associated Microglia

🧬 ACSL4 🏥 alzheimers 📖 45🏛 5

✅ 0.50 ✨ 0.63 💥 0.00

## Mechanistic Overview...

mechanistic 0.80

ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matter Degeneration in Alzheimer's Disease

🧬 ACSL4 🏥 alzheimers 📖 48🏛 4

✅ 0.60 ✨ 0.56 💥 0.00

## Mechanistic Overview...

mechanistic 0.79

Selective APOE4 Degradation via Proteolysis Targeting Chimeras (PROTACs)

🧬 APOE 🏥 neurodegeneration 📖 87🏛 2

✅ 0.20 ✨ 0.90 💥 0.70

## Mechanistic Overview...

mechanistic 0.79

Targeting SASP-Complement Amplification Through HIF-1α Downstream Effectors

🧬 C1QA, C1QB, C3, IL1B 🏥 neurodegeneration 📖 10🏛 1

✅ 0.78 ✨ 0.65 💥 0.75

## Mechanistic Overview...

mechanistic 0.78

Competitive APOE4 Domain Stabilization Peptides

🧬 APOE 🏥 neurodegeneration 📖 84🏛 2

✅ 0.20 ✨ 0.80 💥 0.60

## Mechanistic Overview...

mechanistic 0.78

LAMP2A Liquid-Liquid Phase Separation Defects in Dopaminergic Neurons Create Selective Vulnerability to SNCA-Mediated CM

🧬 LAMP2 🏥 neurodegeneration 📖 5🏛 1

✅ 0.00 ✨ 0.92 💥 0.00

LAMP2A exists in the lysosomal membrane as both monomers and higher-order oligomers that undergo liquid-liquid phase separation (LLPS) to form membran...

mechanistic 0.78

SASP-Driven Aquaporin-4 Dysregulation

🧬 AQP4 🏥 neurodegeneration 📖 34🏛 2

✅ 0.60 ✨ 0.65 💥 0.72

## Mechanistic Overview...

mechanistic 0.78

ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes Underlies White Matter Degeneration in Alzheimer

🧬 ACSL4 🏥 alzheimers 📖 44🏛 4

✅ 0.60 ✨ 0.54 💥 0.00

## Mechanistic Overview...

mechanistic 0.78

TFEB Nuclear Translocation to Reset Lysosomal-Hypoxia Axis

🧬 TFEB, MTOR 🏥 neurodegeneration 📖 21🏛 1

✅ 0.65 ✨ 0.70 💥 0.68

## Mechanistic Overview...

mechanistic 0.78

PDE4 Inhibition as Inflammatory Reset for PD Oligodendrocytes

🧬 PDE4A, PDE4B, PDE4D 🏥 neuroinflammation 📖 13🏛 1

✅ 0.62 ✨ 0.58 💥 0.75

## Mechanistic Overview...

mechanistic 0.78

Transcriptional Autophagy-Lysosome Coupling

🧬 FOXO1 🏥 neurodegeneration 📖 52🏛 2

✅ 0.67 ✨ 0.72 💥 0.72

## Mechanistic Overview...

mechanistic 0.78

LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Priming Engine in Disease-Associated Microglia

🧬 LPCAT3 🏥 alzheimers 📖 44🏛 4

✅ 0.58 ✨ 0.58 💥 0.00

## Mechanistic Overview...

mechanistic 0.78

Exosomal SNCA Propagation from Lysosome-Compromised Neurons Contains a Distinct Lysosomal Proteome Signature that Primes

🧬 SNCA 🏥 neurodegeneration 📖 5🏛 1

✅ 0.00 ✨ 0.85 💥 0.00

Dopaminergic neurons with lysosomal stress (either from GBA1 mutations, VPS35 dysfunction, or age-related LAMP2A decline) release exosomes enriched in...

mechanistic 0.78

LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Substrate Pools in Disease-Associated Microglia

🧬 LPCAT3 🏥 alzheimers 📖 43🏛 3

✅ 0.58 ✨ 0.52 💥 0.00

## Mechanistic Overview...

mechanistic 0.77

ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes via PUFA-PE Peroxidation

🧬 ALOX15 🏥 alzheimers 📖 44🏛 4

✅ 0.50 ✨ 0.62 💥 0.00

## Mechanistic Overview...